Increased Prevalence of K-ras Oncogene Mutations in Lung Adenocarcinoma

Cancer Research

Volumn 55, Issue 7, 1995, Pages 1444-1447

  Mills, Nancy E ^a   Fishman, Charles L ^a   Rom, William N ^a   Dubin, Neil ^a   Jacobson, Daniel R ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DNA DETERMINATION; GENE MUTATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

ADENOCARCINOMA; BASE SEQUENCE; CODON; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, RAS; HUMAN; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028958222     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rodenhuis, S. and Slebos, R.J.C. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res. (Suppl), 52: 2665s-2669s, 1992.
2. Sugio, K. Ishida, T. Yokoyama, H. Inoue, T. Sugimachi, K. and Sasazuki, T. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res. 52: 2903-2906, 1992.
3. Mitsudomi, T. Viallet, J. Mulshine, J.L. Linnoila, R.I. Minna, J.D. and Gazdar, A.F. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene, 6: 1353-1362, 1991.
4. Kobayashi, T. Tsuda, H. Noguchi, M. Hirohashi, S. Shimosato, Y. Goya, T. and Hayata, Y. Association of point mutation in c-Ki-ra5 oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer (Phila.), 66: 289-294, 1990.
5. Slebos, R.J.C. Kibbelaar, R.E. Dalesio, 0. Kooistra, A. Stam, J. Meijer, C.J.L.M. Wagenaar, S.S. Vanderschueren, R.G.J.R.A. van Zandwijk, N. Mooi, W.J. Bos, J.L. and Rodenhuis, S. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med. 323: 561-565, 1990.
6. Mitsudomi, T. Steinberg, S.M. Oie, H.K. Mulshine, J.L. Phelps, R. Viallet, J. Pass, H. Minna, J.D. and Gazdar, A.F. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res. 57: 4999-5002, 1991.
7. Farr, C.J. Saiki, R.K. Erlich, H.A. McCormick, F. and Marshall, C.J. Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc. Natl. Acad. Sci. USA, 85: 1629-1633, 1988.
8. Ball, E.D. Mills, L.E. Neubauer, A. and Liu, E. Detection of minimal acute myeloid leukemia cells in bone marrow by probing for mutated ras genes using the polymerase chain reaction. Prog. Clin. Biol. Res. 333: 499-506, 1990.
9. Jacobson, D.R. and Mills, N.E. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. Oncogene, 9: 553-563, 1994.
10. Wright, D.K. and Manos, M.M. Sample preparation from paraffin-embedded tissues. In: M.A. Innis, D.H. Gelfand, J.J. Sninsky, and T.J. White (eds.), PCR Protocols: a Guide to Methods and Applications, pp. 153-158. San Diego, CA: Academic Press, Inc. 1990.
11. Ahuja, H.G. Foti, A. Bar-Eli, M. and Cline, M.J. The pattern of mutational involvement of ras genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood, 75: 1684-1690, 1990.
12. Toksoz, D. Farr, C.J. and Marshall, C.J. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia. Oncogene, /: 409-413, 1987.
13. Syvanen, A.C. Soderlund, H. Laaksonen, E. Bengtstrom, M. Turunen, M. and Palotie, A. N-ras gene mutations in acute myeloid leukemia: accurate detection by solid-phase minisequencing. Int. J. Cancer, 50: 713-718, 1992.
14. Bashey, A. Gill, R. Levi, S. Fair, C.J. Clutterbuck, J.L. Millar, J.L. Pragnell, I.B. and Marshall, C.J. Mutational activation of the N-ras oncogene assessed in primary clonogenic culture of acute myeloid leukemia (AML): implications for the role of N-ras mutation in AML pathogenesis. Blood, 79: 981-989, 1992.
15. Rodenhuis, S. Slebos, R.J.C. Boot, A.J.M. Evers, S.G. Mooi, W.J. Wagenaar, S.S. van Bodegom, P.C. and Bos, J.L. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res. 48: 5738-5741, 1988.
16. Birrer, M.J. and Brown, P.H. Application of molecular genetics to the early diagnosis and screening of lung cancer. Cancer Res. 52: 2658s-2664s, 1992.
17. Szabo, E. Birrer, M.J. and Mulshine, J.L. Early detection of lung cancer. Semin. Oncol. 20: 374-382, 1993.
18. Toksoz, D. Farr, C.J. and Marshall, C.J. Ras genes and acute myeloid leukemia. Br. J. Haematol. 71: 1-6, 1989.
19. Eckert, K.A. and Kunkel, T.A. DNA polymerase fidelity and the polymerase chain reaction. PCR Methods Appl. 1: 17-24, 1991.
20. Mills, N.E. Fishman, C.L. Scholes, J. Anderson, S.E. Rom, W.N. and Jacobson. D.R. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung diagnosis. J. Natl. Cancer Inst. in press.
21. Mao, L. Hruban, R.H. Boyle, J.O. Tockman, M. and Sidransky, D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 54: 1634-1637, 1994.